CT Antigen TCR-Engineered T Cells for Myeloma
Clinical trial NCT01892293 · TERMINATED
Trial details
- NCT number
- NCT01892293
- Sponsor
- Adaptimmune
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-15
- Primary completion
- 2014-12-10
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.